Designer Functional Nanomedicine for Myocardial Repair by Regulating the Inflammatory Microenvironment

Chunping Liu,Zhijin Fan,Dongyue He,Huiqi Chen,Shihui Zhang,Sien Guo,Bojun Zheng,Huan Cen,Yunxuan Zhao,Hongxing Liu,Lei Wang
DOI: https://doi.org/10.3390/pharmaceutics14040758
IF: 6.525
2022-03-31
Pharmaceutics
Abstract:Acute myocardial infarction is a major global health problem, and the repair of damaged myocardium is still a major challenge. Myocardial injury triggers an inflammatory response: immune cells infiltrate into the myocardium while activating myofibroblasts and vascular endothelial cells, promoting tissue repair and scar formation. Fragments released by cardiomyocytes become endogenous “danger signals”, which are recognized by cardiac pattern recognition receptors, activate resident cardiac immune cells, release thrombin factors and inflammatory mediators, and trigger severe inflammatory responses. Inflammatory signaling plays an important role in the dilation and fibrosis remodeling of the infarcted heart, and is a key event driving the pathogenesis of post-infarct heart failure. At present, there is no effective way to reverse the inflammatory microenvironment in injured myocardium, so it is urgent to find new therapeutic and diagnostic strategies. Nanomedicine, the application of nanoparticles for the prevention, treatment, and imaging of disease, has produced a number of promising applications. This review discusses the treatment and challenges of myocardial injury and describes the advantages of functional nanoparticles in regulating the myocardial inflammatory microenvironment and overcoming side effects. In addition, the role of inflammatory signals in regulating the repair and remodeling of infarcted hearts is discussed, and specific therapeutic targets are identified to provide new therapeutic ideas for the treatment of myocardial injury.
pharmacology & pharmacy
What problem does this paper attempt to address?
Based on the content of the provided literature, the main problem that this paper attempts to solve is the myocardial repair problem after acute myocardial infarction (AMI), especially promoting repair by regulating the myocardial inflammatory micro - environment. Specifically, the paper focuses on the following aspects: 1. **Inflammatory response after myocardial injury**: Myocardial injury will trigger an inflammatory response. Immune cells infiltrate into the myocardium, activate myofibroblasts and vascular endothelial cells, and promote tissue repair and scar formation. Fragments released by cardiomyocytes become endogenous "danger signals", which are recognized by cardiac pattern - recognition receptors (PRRs), activating resident cardiac immune cells, releasing clotting factors and inflammatory mediators, and triggering a severe inflammatory response. 2. **The role of inflammatory signals in myocardial repair**: Inflammatory signals play an important role in the process of myocardial dilation and fibrotic remodeling, and are key events driving heart failure after myocardial infarction. At present, there are no effective methods to reverse the inflammatory micro - environment of the damaged myocardium, so there is an urgent need to find new treatment and diagnostic strategies. 3. **The application of nanomedicine**: Nanomedicine has generated a series of promising applications by applying nanoparticles for disease prevention, treatment and imaging. The paper discusses the advantages of functional nanoparticles in regulating the myocardial inflammatory micro - environment, overcoming side effects and improving treatment effects. 4. **Identification of specific treatment targets**: The paper also discusses the role of inflammatory signals in regulating ischemic myocardial repair and remodeling, and attempts to identify specific treatment targets, providing new ideas for the diagnosis and treatment of myocardial injury. In summary, this paper aims to explore and evaluate the potential of nanomedicine in myocardial injury repair, especially its role in regulating the myocardial inflammatory micro - environment, in order to provide new methods and strategies for the clinical treatment of myocardial injury.